服务热线
15339069646服务热线
15339069646| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-IFNG mAbs [Indematug Biosimilar] (MABL-4803) | MABL-4803 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-SNCA/PARK1/PARK4 mAbs [Indenebart Biosimilar] (MABL-4804) | MABL-4804 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-GUCY2C mAbs [Indusatumab Biosimilar] (MABL-4805) | MABL-4805 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD19 mAbs [Inebilizumab Biosimilar] (MABL-4806) | MABL-4806 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD40;MSLN mAbs [Inezetamab Biosimilar] (MABL-4807) | MABL-4807 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Lambda;Kappa |
| Anti-TNF/TNFA mAbs [Infliximab Biosimilar] (MABL-4808) | MABL-4808 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;KLRK1/NKG2D/CD314 mAbs [Ingitamig Biosimilar] (MABL-4809) | MABL-4809 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-KDR/CD309/VEGFR2 mAbs [Inlecitug Biosimilar] (MABL-4810) | MABL-4810 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SIGLEC2/CD22 mAbs [Inotuzumab Biosimilar] (MABL-4811) | MABL-4811 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-ITGAVB3/CD61/VNR mAbs [Intetumumab Biosimilar] (MABL-4812) | MABL-4812 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TRBV6&TRBV10 mAbs [Invikafusp Biosimilar] (MABL-4813) | MABL-4813 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Iparomlimab Biosimilar] (MABL-4814) | MABL-4814 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CTLA4/CD152 mAbs [Ipilimumab Biosimilar] (MABL-4815) | MABL-4815 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF8/CD30 mAbs [Iratumumab Biosimilar] (MABL-4816) | MABL-4816 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SLC1A5 mAbs [Idactamab Biosimilar] (MABL-4786) | MABL-4786 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Dabigatran mAbs [Idarucizumab Biosimilar] (MABL-4787) | MABL-4787 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-LAG3/CD223 mAbs [Ieramilimab Biosimilar] (MABL-4788) | MABL-4788 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-EPHA3 mAbs [Ifabotuzumab Biosimilar] (MABL-4789) | MABL-4789 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-B7H3/CD276 mAbs [Ifinatamab Biosimilar] (MABL-4790) | MABL-4790 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-AGM6/CD79B mAbs [Iladatuzumab Biosimilar] (MABL-4791) | MABL-4791 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn